The Irrelevance of In Vitro Dissolution in Setting Product Specifications for Drugs Like Dextromethorphan That are Subject to Lysosomal Trapping

This publication has 36 references indexed in Scilit:

• Prediction of Relative In Vivo Metabolite Exposure from In Vitro Data Using Two Model Drugs: Dextromethorphan and Omeprazole
  Drug Metabolism and Disposition, 2012
• Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling
  Clinical Pharmacokinetics, 2011
• Mechanisms of Amine Accumulation in, and Egress from, Lysosomes
  Bioanalysis, 2009
• Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling
  Xenobiotica, 2009
• Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data
  The AAPS Journal, 2009
• Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs
  Drug Metabolism and Disposition, 2007
• Development of a chromatographic bioreactor based on immobilized β-glucuronidase on monolithic support for the determination of dextromethorphan and dextrorphan in human urine
  Journal of Pharmaceutical and Biomedical Analysis, 2004
• An algorithm for predicting tissue : Blood partition coefficients of organic chemicals fromn‐octanol: Water partition coefficient data
  Journal of Toxicology and Environmental Health, 1995
• Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans.
  Journal of Clinical Investigation, 1993
• Per Cent Absorbed Time Plots Derived from Blood Level and/or Urinary Excretion Data
  Journal of Pharmaceutical Sciences, 1963